Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and AdV: A phase III, prospective, multicentre clinical trial
Erkrankungsgruppe:
Sonstiges
Organsystem:
Blut
Stadium:
Therapierefraktär
Standort:
Essen
EudraCT:
2018-000853-29
Prüfplan-Code:
TRACE
Phase:
III
Prüfsubstanz:
Human multivirus-specific T cells enriched for specificity against Cytomegalovirus, Adenovirus and Epstein-Barr Virus